The Swedish Family-Cancer Database has been the major source of population-based prospective data on familial risks on most cancers, including prostate cancer. In the present review, I focus on three lines of family studies with novel results. The covered studies originate from the same database with publication dates spanning a period of somewhat over 3 years. Age-specific hazard ratios (HRs) of incident prostate cancer and fatal prostate cancer were determined according to the number of affected relatives. Cumulative risks for incidence and death were calculated for the various types of families. Finally, data on the familial association of prostate cancer with some other cancers were reviewed. If the father had prostate cancer, the HR fo...
Background: Familial cancer can be defined through the occurrence of the same cancer in two or more ...
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysi...
Background Many prostate cancer (PC) risk assessment models have been developed, however almost none...
Abstract The Swedish Family-Cancer Database has been used for some 10 years in the study of familial...
The objectives of this study were to investigate the effect of family history on prostate cancer ris...
Background: Familial clustering of incident prostate cancer and some cancers at other discordant sit...
Objectives. A family history of prostate cancer is associated with a higher risk for prostate cancer...
Background Family history is a strong risk factor for prostate cancer. The aim of this study was to ...
Familial risks for cancer are important for clinical counseling and understanding cancer etiology. M...
A family history of prostate cancer has long been identified as an important risk factor for develop...
Background: Familial prostate cancer risk estimates are inflated by clinically insignificant low-ris...
A family history of prostate cancer has long been identified as an important risk factor for develop...
Simple Summary Familial cancer can be defined through the occurrence of the same cancer in two or mo...
BACKGROUND: The question of whether having a family history of prostatic borderline or in situ neopl...
The authors examined the relation between family history of prostate cancer and the risk of this can...
Background: Familial cancer can be defined through the occurrence of the same cancer in two or more ...
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysi...
Background Many prostate cancer (PC) risk assessment models have been developed, however almost none...
Abstract The Swedish Family-Cancer Database has been used for some 10 years in the study of familial...
The objectives of this study were to investigate the effect of family history on prostate cancer ris...
Background: Familial clustering of incident prostate cancer and some cancers at other discordant sit...
Objectives. A family history of prostate cancer is associated with a higher risk for prostate cancer...
Background Family history is a strong risk factor for prostate cancer. The aim of this study was to ...
Familial risks for cancer are important for clinical counseling and understanding cancer etiology. M...
A family history of prostate cancer has long been identified as an important risk factor for develop...
Background: Familial prostate cancer risk estimates are inflated by clinically insignificant low-ris...
A family history of prostate cancer has long been identified as an important risk factor for develop...
Simple Summary Familial cancer can be defined through the occurrence of the same cancer in two or mo...
BACKGROUND: The question of whether having a family history of prostatic borderline or in situ neopl...
The authors examined the relation between family history of prostate cancer and the risk of this can...
Background: Familial cancer can be defined through the occurrence of the same cancer in two or more ...
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysi...
Background Many prostate cancer (PC) risk assessment models have been developed, however almost none...